Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin.
about
Clusterin: a key player in cancer chemoresistance and its inhibitionComparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.Silence of MACC1 expression by RNA interference inhibits proliferation, invasion and metastasis, and promotes apoptosis in U251 human malignant glioma cells.MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.Inhibition of protein kinase C by isojacareubin suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo.Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic studyHeat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.The effects of shRNA-mediated gene silencing of transcription factor SNAI1 on the biological phenotypes of breast cancer cell line MCF-7.Correction: liang, j., et Al. Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and e-cadherin. Int. J. Mol. Sci. 2012, 13, 10594-10607.Downregulation of CD147 by chitooligosaccharide inhibits MMP-2 expression and suppresses the metastatic potential of human gastric cancer.Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
P2860
Q24567925-208F10D3-A552-418F-8089-F08397F12137Q33638790-B28F1673-9894-4DA6-B87C-4B8A2594719EQ35653078-977BF1EB-4DA1-4445-A3D0-C5C8C3EF3CD8Q35692510-D94024FE-18DB-44D9-9043-968A3EA3BEB7Q35922102-6BE25C02-6CF9-40FC-B4BD-BFEBFB6074CAQ37244398-1858340A-23F8-47DF-BC47-04E5E21D1A58Q38725577-B9C129BB-6B4D-466C-8241-65824CD37D0CQ39051478-25BAEBA5-1396-4FE8-AAD5-E3913E7CD333Q40042676-9A1D30DA-A65C-4DC6-A0A6-90A1BE643FAEQ40892047-7D7EC17A-BEC1-43AE-840F-5B9B08DCE311Q41491991-08422FF3-5D3A-4295-A0AA-7039C7FDE92FQ49015972-02008851-33C6-4F29-96E3-F8A7B02BBD7CQ51069587-905E04A0-6D5A-444C-A6E9-8A120D945881
P2860
Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@en
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@nl
type
label
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@en
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@nl
prefLabel
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@en
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@nl
P2093
P2860
P356
P1476
Antisense oligonucleotide agai ...... loproteinase-2 and E-cadherin.
@en
P2093
P2860
P304
10594-10607
P356
10.3390/IJMS130810594
P407
P50
P577
2012-08-23T00:00:00Z